JPRN-UMIN000026844Recruiting未知
lcerative colitis- real world study for the effects of biologics, anti-TNF alpha- golimumab in remission- induction and maintenance- (UC- BINGO) study - UC- BINGO study
Saitama Medical University, Saitama Medical Center0 sites40 target enrollmentStarted: June 1, 2017Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Enrollment
- 40
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 15years-old to 70years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients who has contraindication of golimumab Patients in pregnancy and lactation period Patients who has and had malignancy Patients who don nott have informed conents Patients determined not to be suitable for this study by physicians
Investigators
Similar Trials
Recruiting
Not Applicable
Study to Assess Change in Disease Activity of Risankizumab Treatment in Adult Participants With Moderate to Severe Ulcerative ColitisUlcerative ColitisNCT06764706AbbVie200
Completed
Not Applicable
nderstanding the Impact of Ulcerative COlitis aNd Its AssoCiated disease burdeN on patlentslcerative colitisJPRN-UMIN000018082AbbVie GK1,800
Completed
Phase 2
Metformin in Patients With Ulcerative Colitis Treated With MesalamineInflammatory Bowel DiseasesNCT05553704Tanta University60
Completed
Phase 2
Minocyclin in Ulcerative Colitis as Added on TherapyInflammatory Bowel DiseasesNCT06201793Mostafa Bahaa46
Completed
Not Applicable
Outcomes Research for Ulcerative Colitis using Patient Focused RegistryJPRN-UMIN000031995Takeda Pharmaceutical Company, Limited2,000